Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felicitas Thol

Showing results (31-40 of 126) with videos related to

Pageof 13
Sort By:
Frontiers in Oncology|July 25, 2022
Clonal Evolution at First Sight: A Combined Visualization of Diverse Diagnostic Methods Improves Understanding of Leukemic ProgressionSarah Sandmann, Yvonne Lisa Behrens, Claudia Davenport, et al.
Blood|February 15, 2019
Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantationNico Gagelmann, Markus Ditschkowski, Rashit Bogdanov, et al.
Journal of Cellular Biochemistry|February 27, 2010
Erythrocytes serve as a reservoir for cellular and extracellular sphingosine 1-phosphateConstantin Bode, Sven-Christian Sensken, Ulrike Peest, et al.
Annals of Hematology|April 17, 2014
Lack of noncanonical RAS mutations in cytogenetically normal acute myeloid leukemiaChristoph W M Reuter, Jürgen Krauter, Fredrick O Onono, et al.
Genes, Chromosomes & Cancer|March 29, 2012
Next-generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3-ITD or NPM1 mutationsFelicitas Thol, Britta Kölking, Frederik Damm, et al.
Genes, Chromosomes & Cancer|January 24, 2021
Unbalanced translocation der(5;17) resulting in a TP53 loss as recurrent aberration in myelodysplastic syndrome and acute myeloid leukemia with complex karyotypeDaria Warnstorf, Randa Bawadi, Andrea Schienke, et al.
Annals of Hematology|December 13, 2012
Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemiaFelicitas Thol, Claudia Winschel, Ann-Kathrin Sonntag, et al.
Haematologica|May 25, 2010
IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosisFelicitas Thol, Eva M Weissinger, Jürgen Krauter, et al.
Hemasphere|October 7, 2022
High Molecular and Cytogenetic Risk in Myelofibrosis Does Not Benefit From Higher Intensity Conditioning Before Hematopoietic Cell Transplantation: An International Collaborative AnalysisNico Gagelmann, Rachel B Salit, Thomas Schroeder, et al.
Annals of Hematology|August 28, 2013
Long-term results of a prospective randomized trial evaluating G-CSF priming in intensive induction chemotherapy followed by autologous stem cell transplantation in elderly patients with acute myeloid leukemiaGesine Bug, Steffen Koschmieder, Juergen Krauter, et al.
Pageof 13

Showing results (31-40 of 126) with videos related to

Sort By:
Pageof 13
Frontiers in Oncology|July 25, 2022
Clonal Evolution at First Sight: A Combined Visualization of Diverse Diagnostic Methods Improves Understanding of Leukemic ProgressionSarah Sandmann, Yvonne Lisa Behrens, Claudia Davenport, et al.
Blood|February 15, 2019
Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantationNico Gagelmann, Markus Ditschkowski, Rashit Bogdanov, et al.
Journal of Cellular Biochemistry|February 27, 2010
Erythrocytes serve as a reservoir for cellular and extracellular sphingosine 1-phosphateConstantin Bode, Sven-Christian Sensken, Ulrike Peest, et al.
Annals of Hematology|April 17, 2014
Lack of noncanonical RAS mutations in cytogenetically normal acute myeloid leukemiaChristoph W M Reuter, Jürgen Krauter, Fredrick O Onono, et al.
Genes, Chromosomes & Cancer|March 29, 2012
Next-generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3-ITD or NPM1 mutationsFelicitas Thol, Britta Kölking, Frederik Damm, et al.
Genes, Chromosomes & Cancer|January 24, 2021
Unbalanced translocation der(5;17) resulting in a TP53 loss as recurrent aberration in myelodysplastic syndrome and acute myeloid leukemia with complex karyotypeDaria Warnstorf, Randa Bawadi, Andrea Schienke, et al.
Annals of Hematology|December 13, 2012
Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemiaFelicitas Thol, Claudia Winschel, Ann-Kathrin Sonntag, et al.
Haematologica|May 25, 2010
IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosisFelicitas Thol, Eva M Weissinger, Jürgen Krauter, et al.
Hemasphere|October 7, 2022
High Molecular and Cytogenetic Risk in Myelofibrosis Does Not Benefit From Higher Intensity Conditioning Before Hematopoietic Cell Transplantation: An International Collaborative AnalysisNico Gagelmann, Rachel B Salit, Thomas Schroeder, et al.
Annals of Hematology|August 28, 2013
Long-term results of a prospective randomized trial evaluating G-CSF priming in intensive induction chemotherapy followed by autologous stem cell transplantation in elderly patients with acute myeloid leukemiaGesine Bug, Steffen Koschmieder, Juergen Krauter, et al.
Pageof 13